Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas

被引:19
作者
Baba, Seiji [2 ]
Hara, Akira [1 ]
Kato, Keizo [2 ]
Long, Nguyen Khanh [2 ]
Hatano, Yuichiro [1 ]
Kimura, Masashi [3 ]
Okano, Yukio [3 ]
Yamada, Yasuhiro [1 ]
Shibata, Toshiyuki [2 ]
机构
[1] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu 5011194, Japan
[2] Gifu Univ, Grad Sch Med, Dept Oral & Maxillofacial Sci, Gifu 5011194, Japan
[3] Gifu Univ, Grad Sch Med, Dept Mol Pathobiochem, Gifu 5011194, Japan
关键词
CHFR; oral squamous cell carcinomas; hypermethylation; aurora; normal mucosa; MITOTIC STRESS CHECKPOINT; EPIGENETIC INACTIVATION; MICROTUBULE INHIBITORS; TUMOR SUPPRESSION; MULTIPLE GENES; GASTRIC-CANCER; AURORA-A; METHYLATION; EXPRESSION; PROTEIN;
D O I
10.3892/or_00000552
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Recent studies have shown that promoter hypermethylation of tumor suppressor genes is an important factor in carcinogenesis of several human organs. The purpose of this study was to examine the methylation status of CHFR, a novel cell cycle regulatory gene, in both primary oral cancer tumors and the adjacent normal mucosa, and to clarify the relation between the methylation status and expression of the CHFR-related chromosomal passenger protein Aurora-A. The methylation status of the CHFR gene was examined by the methylation-specific PCR (MSP) in 49 primary oral squamous cell carcinomas (OSCC) and 6 OSCC cell lines. In 13 cases, the adjacent normal oral mucosal tissues were also examined. Normal oral mucosa from 18 healthy volunteers was used as the control. The mRNA level of Aurora-A and CHFR in OSCC cell lines was investigated by real-time RT PCR and the protein expression of Aurora-A in certain tumor samples was confirmed by immunohistochemistry. Aberrant promoter methylation of the CHFR gene was detected in 34.7% (17 of 49) of OSCC cases. As for the 13 OSCC cases with paired cancerous and adjacent normal tissues, promoter hypermethylation of the CHFR gene was detected in 46.1% (6 of 13) of the cancerous tissues. In contrast, promoter hypermethylation of the CHFR gene was recognized in only 7.7% (1 of 13) of the surrounding normal mucosa. No hypermethylation of the CHFR gene was detected in healthy volunteers. Only one OSCC cell line shows hypermethylation of the CHFR gene with concurrently silenced mRNA expression, however, Aurora-A was expressed abundantly in all cell lines. Furthermore, there is no significant relationship between methylation status of the CHFR gene and Aurora-A protein expression in OSCC. Hypermethylation of the CHFR gene was detected in a certain part of OSCC cases whereas it had very low frequency in adjacent normal oral tissues. Although further study is needed, Aurora-A gene expression seems to be independent from methylation status of the CHFR gene in OSCC.
引用
收藏
页码:1173 / 1179
页数:7
相关论文
共 39 条
[1]
Aurora-A: the maker and breaker of spindle poles [J].
Barr, Alexis R. ;
Gergely, Fanni .
JOURNAL OF CELL SCIENCE, 2007, 120 (17) :2987-2996
[2]
Second primary tumors and field cancerization in oral and oropharyngeal cancer: Molecular techniques provide new insights and definitions [J].
Braakhuis, BJM ;
Tabor, MP ;
Leemans, CR ;
van der Waal, I ;
Snow, GB ;
Brakenhoff, RH .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (02) :198-206
[3]
Mutations of mitotic checkpoint genes in human cancers [J].
Cahill, DP ;
Lengauer, C ;
Yu, J ;
Riggins, GJ ;
Willson, JKV ;
Markowitz, SD ;
Kinzler, KW ;
Vogelstein, B .
NATURE, 1998, 392 (6673) :300-303
[4]
Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance [J].
Chang, HW ;
Chow, V ;
Lam, KY ;
Wei, WI ;
Yuen, APW .
CANCER, 2002, 94 (02) :386-392
[5]
CHEN JK, 1990, CANCER-AM CANCER SOC, V66, P1288, DOI 10.1002/1097-0142(19900915)66:6<1288::AID-CNCR2820660632>3.0.CO
[6]
2-N
[7]
Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma [J].
Chen, Kangmei ;
Sawhney, Raja ;
Khan, Mumtaz ;
Benninger, Michael S. ;
Hou, Zizheng ;
Sethi, Seema ;
Stephen, Josena K. ;
Worsham, Maria J. .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2007, 133 (11) :1131-1138
[8]
Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation [J].
Cheung, HW ;
Ching, YP ;
Nicholls, JM ;
Ling, MT ;
Wong, YC ;
Hui, N ;
Cheung, A ;
Tsao, SW ;
Wang, Q ;
Yeun, PW ;
Lo, KW ;
Jin, DY ;
Wang, XH .
MOLECULAR CARCINOGENESIS, 2005, 43 (04) :237-245
[9]
Frequent hypermethylation of the 5′ CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer [J].
Corn, PG ;
Summers, MK ;
Fogt, F ;
Virmani, AK ;
Gazdar, AF ;
Halazonetis, TD ;
El-Deiry, WS .
CARCINOGENESIS, 2003, 24 (01) :47-51
[10]
Aurora kinases as anticancer drug targets [J].
Gautschi, Oliver ;
Heighway, Jim ;
Mack, Philip C. ;
Purnell, Phillip R. ;
Lara, Primo N., Jr. ;
Gandara, David R. .
CLINICAL CANCER RESEARCH, 2008, 14 (06) :1639-1648